RxDoctor Payments DataLook up a doctor →

Orlando Puente, MD

General Surgery · Miami, FLNPI 1811976459

Payments from drug & device makers

$12,141,556in general payments, 2019–2025

Across 533 payments — averaging $22,780 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$8.4M
  • Eli Lilly$2.1M
  • Modernatx, Inc.$946K
  • Eisai Inc.$287K
  • Novartis$189K
  • E.r. Squibb & Sons, L.L.C.$122K
  • plus $143K from 9 others
$255,488in research payments, 2019–2025

Across 6 payments — averaging $42,581 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$252K
  • Pfizer$3K

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,141,556 in reported general payments places this provider in the 95th percentile of 54 general surgery providers in Florida.

See all general surgery providers in Florida

Medicare billing

Part B allowed, 2024
$11,675
Medicare patients
257
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other general surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →